The State of Patient Access: Maximizing Access Strategies in the Era of Biosimilars
The rapid evolution of biosimilars is driving competitive pricing pressure and intensifying access challenges. In light of market and regulatory shifts, how are brands rethinking their access strategies?
In this BioPharma Dive webinar, Hannah Baxter, partner at The Dedham Group, and Steve Callahan, senior director of Advisory & Insights, MMIT, share insights from our 2025 State of Patient Access survey.
Review key insights from the speakers in this executive summary of the discussion.
Access the Webinar Recording and Executive Summary
Hear commonly cited challenges impeding patient access for both medical and pharmacy benefit products.
Learn how IRA provisions may shift manufacturers’ investment priorities and access strategies.
Understand pivotal factors supporting (and hindering) biosimilar investment and development.